MOUNTAIN VIEW, Calif., July 29 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will releaseits second quarter 2010 financial results after the market closes on Thursday, August 5, 2010. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on
Interested parties may access the live conference call via telephone by dialing (877) 941-1466 U.S. or (480) 629-9678 (International) and quoting Conference ID 4336037, or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Thursday, August 5, 2010 through Thursday, August 12, 2010 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4336037.
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.
SOURCE IRIDEX Corporation
Subscribe to our Free Newsletters!
Nissen fundoplication is an acid reflux surgical procedure used to treat gastro-esophageal reflux ...
Myelodysplastic syndromes are a group of bone marrow stem cell disorders marked by ineffective ...
Endoscopic Retrograde Cholangio-Pancreatography uses endoscopy and fluoroscopic imaging for ...View All